Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Status:
Completed
Trial end date:
2018-07-02
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, vehicle controlled, double-blind Phase 2 study in
pediatric patients age 2-17 years old with mild to moderate atopic dermatitis.